Litcius/Paper detail

Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer

Roger Li, Luigi Nocera, Kyle Rose, Daniele Raggi, Shreyas Naidu, Chiara Mercinelli, Antonio Cigliola, Valentina Tateo, Damiano Alfio Patanè, G. Daniel Grass, Scott M. Gilbert, Wade J. Sexton, Marco Bandini, Marco Moschini, Alberto Briganti, Francesco Montorsi, Philippe E. Spiess, Andrea Necchi

2024European Urology Oncology19 citationsDOI

Topics & Concepts

MedicineCystectomyPembrolizumabBladder cancerCisplatinUrothelial cancerOncologyUrologyChemotherapyUrothelial carcinomaNeoadjuvant therapyInternal medicineCancerImmunotherapyBreast cancerBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis
Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer | Litcius